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Application of Laparoscopic Surgery in Gynecological
Oncology
Wen-Chun Chang,1 Long-Chien Lee,2 Su-Cheng Huang,1 Bor-Ching Sheu1*
The role of laparoscopic surgery in the management of gynecological cancers continues to expand. For
early-stage cervical cancer, laparoscopically assisted radical vaginal hysterectomy is feasible, and radical
vaginal trachelectomy with laparoscopic pelvic lymphadenectomy has emerged as a safe option for
women who desire fertility preservation. In the treatment of early-stage endometrial cancer, the surgical
staging of laparoscopic hysterectomy, peritoneal washings and pelvic lymph node dissection is effective
and safe when compared with the same surgery performed via laparotomy. In ovarian malignancies, 
laparoscopic surgery has been incorporated to manage early-stage cancers.
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The use of laparoscopy in oncological procedures,
whether alone or in combination with other ap-
proaches, is growing. Technical advances have
made modern-day laparoscopy more widely appli-
cable, and it is now possible to perform laparo-
scopically all of the International Federation of
Gynecology and Obstetrics (FIGO) standard sur-
gical staging procedures for early-stage gyneco-
logical cancer.1–4 The advantages of laparoscopic
staging are smaller incisions and thus lower post-
operative morbidity, faster postoperative recovery,5
and quicker commencement of adjuvant radio-
therapy or chemotherapy.6 However, laparoscopic
surgery (LS) technically hampers the removal of
large tumors, and has a potential risk of trocar
site metastasis. In this paper, the application of
LS in endometrial, cervical and ovarian cancer is
discussed.
Laparoscopic Lymphadenectomy
Currently, advanced laparoscopic techniques are
used to evaluate and treat cervical, endometrial
and ovarian malignancies. Assessment of the inva-
sion of the pelvic lymph nodes is part of the stag-
ing process for these gynecological cancers. In
most cases, imaging techniques cannot reliably
evaluate lymphatic spread. Endoscopy offers a sat-
isfactory means of determining the surgical stage
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of the disease. Pelvic lymphadenectomy can in-
fluence the therapeutic strategy, especially when a
combination of treatments is proposed. Specifi-
cally, transperitoneal laparoscopic lymphadenec-
tomy that includes the pelvic and para-aortic
nodes is a feasible and efficacious procedure in
the management of certain gynecological malig-
nancies. Figure 1 depicts the typical patterns of
lymphatic dissemination of gynecological cancer.
The pelvic lymph nodes include the common iliac,
external iliac, internal iliac (hypogastric), and ob-
turator nodes. The para-aortic lymph nodes are
sampled bilaterally to the level of the inferior
mesenteric artery.7 The level of dissection that is
considered adequate is controversial.8 Some au-
thors have suggested that the periaortic dissection
should extend to the renal vessels.9,10
Tables 1–3 show that laparoscopy provides
an equivalent lymph node yield compared with
laparotomy in gynecological cancer. Some inves-
tigators have reported their experience with 650
pelvic and periaortic lymphadenectomies per-
formed for gynecological malignancies; 396 of
which were for cervical cancer, 112 for endometrial
cancer, and 44 for ovarian cancer.11 After a learn-
ing period of approximately 20 procedures, a con-
stant number of pelvic lymph nodes (16.9–21.9)
were removed. Pelvic lymphadenectomy took 28
minutes, and para-aortic lymphadenectomy took
Para-aortic
Common iliac
External iliac
Obturator
Figure 1. Patterns of lymphatic dissemination of gynecolog-
ical cancer. Gynecological cancer can spread via lymphatics
to the pelvic and periaortic lymph nodes.
36–62 minutes. The number of para-aortic lymph
nodes removed has increased continuously from
5.5 to 18.5. The number of lymph nodes removed
and the duration of pelvic lymphadenectomy were
independent from the body mass index of the
patient. The overall complication rate was 8.7%,
with 2.9% intraoperative (vessel or bowel injury)
and 5.8% postoperative complications. Figure 2
shows the operative procedures of laparoscopic
pelvic lymphadenectomy.
Endometrial Cancer
The risk factors of endometrial cancer, such as di-
abetes, hypertension and obesity, have been well
documented to increase surgical risk and confer
a higher perioperative morbidity and mortality.
Therefore, the adoption and utilization of LS to
treat this patient population is an attractive op-
tion.12,13 However, there are some limitations as-
sociated with LS, and women with a uterine size
that exceeds a transversal diameter of 8 cm, clini-
cally advanced disease, or other important health
problems are not candidates for LS.5 The surgical
approach includes washing cytology, hysterectomy,
bilateral salpingo-oophorectomy, and lymphaden-
ectomy. In women with endometrial cancer, the
operating time, number of lymph glands resected,
complication rate, recurrence rate, and survival out-
come were the same with laparoscopic and open
surgery (Table 1).14–21 In addition, LS was associ-
ated with a shorter hospital stay14–21 and a better
postoperative quality of life.5,20,22 These data
demonstrate that the laparoscopic surgical ap-
proach for the treatment of patients with clinical
early-stage endometrial cancer is effective and safe.
Cancer cell dissemination caused by the uter-
ine manipulator during LS is an issue of concern,
and several studies have noted a higher vaginal
cuff recurrent rate in LS patients.20,23–28 As far as
we are aware, there have been no studies that
were adequately powered to detect a difference
in vaginal cuff recurrence between patients who
were treated with LS and laparotomy. However,
some authors have suggested that efforts should
W.C. Chang, et al
560 J Formos Med Assoc | 2010 • Vol 109 • No 8
Ta
b
le
 1
.
Co
m
pa
ris
on
 o
f l
ap
ar
os
co
pi
c 
an
d 
la
pa
ro
to
m
ic
 s
ta
gi
ng
 s
ur
ge
ry
 o
f e
nd
om
et
ria
l c
an
ce
r i
n 
th
e 
lit
er
at
ur
es
M
al
ur
 
To
zz
i 
Za
pi
co
 
Ka
lo
gi
an
ni
di
s 
N
ez
ha
t 
M
al
zo
ni
 
Zu
llo
 
G
he
zz
i 
et
 a
l [
14
]
et
 a
l [
15
]
et
 a
l [
16
]
et
 a
l [
17
]
et
 a
l [
18
]
et
 a
l [
19
]
et
 a
l [
20
]
et
 a
l [
21
] 
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
N
um
be
r o
f c
as
es
33
34
62
59
38
37
69
10
0
67
12
7
81
78
40
38
11
7
12
2
LN
 (n
)
16
.1
15
.4
19
.3
18
.2
15
.1
13
.5
15
21
14
11
23
.5
22
.2
11
.5
19
.3
18
20
O
pe
ra
tin
g 
tim
e 
(m
in
)
17
6
16
6
13
6
10
2
16
5
13
0
17
2
13
7
–
–
13
6
12
3
19
7
13
5
19
7
16
0
EB
L 
(m
L)
 
22
9
59
4
24
1
58
6
H
b 
2.
5
H
b 
3.
0
30
0
35
5
22
3
30
9
50
14
5
17
4
28
3
15
0
25
0
H
os
pi
ta
l s
ta
y 
(d
)
8.
6
11
.7
7.
8
11
.4
5.
0
7.1
5
8
3.
6
6.
2
2.
1
5.
1
3.
0
6.
9
3
7
Co
nv
er
si
on
 (%
)
0
7.
9
5.
2
5.
5
13
.4
0
12
.5
Co
m
pl
ic
at
io
n 
(%
)
29
.7
39
.3
–
–
18
.4
38
.8
7
8
23
36
2.
5
2.
5
35
57
.9
14
.5
23
.8
F/
U
 (m
on
)
16
.5
21
.6
44
36
53
51
52
36
.3
29
.6
38
.5
78
79
52
80
Re
cu
rr
en
ce
 (%
)
3.
0
5.
9
12
.6
8.
5
5.
3
5.
4
8.
7
16
5.
9
7.
8
8.
6
11
.5
20
.0
18
.4
11
.9
15
.6
Su
rv
iv
al
 (%
)
83
.9
90
.9
82
.7
86
.5
89
.5
91
.9
93
91
10
0
97
93
.9
91
.1
82
.5
84
.2
94
93
.4
LS
=
la
pa
ro
sc
op
ic
; L
T
=
la
pa
ro
to
m
ic
; L
N
=
ly
m
ph
 n
od
e;
 E
BL
=
es
tim
at
ed
 b
lo
od
 lo
ss
.
Ta
b
le
 2
.
Co
m
pa
ris
on
 o
f l
ap
ar
os
co
pi
c 
an
d 
la
pa
ro
to
m
ic
 ra
di
ca
l h
ys
te
re
ct
om
y 
of
 c
er
vi
ca
l c
an
ce
r i
n 
th
e 
lit
er
at
ur
es
Le
e 
St
ee
d 
Ja
ck
so
n 
Li
 
Za
ka
sh
an
sk
y 
Fr
um
ov
itz
 
Es
ta
pe
 
et
 a
l [
31
]
et
 a
l [
32
]
et
 a
l [
33
]
et
 a
l [
34
]
et
 a
l [
35
]
et
 a
l [
36
]
et
 a
l [
39
]
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
LS
LT
N
um
be
r c
as
es
30
30
71
20
5
50
50
90
35
30
30
35
54
17
14
LN
 (n
)
14
5
N
S
N
S
15
16
21
.3
18
.8
31
21
.8
14
49
18
.6
25
.7
O
pe
ra
tin
g 
tim
e 
(m
in
)
22
1
20
6
21
0
15
0
18
0
12
0
26
3
21
7
31
9
24
3
34
4
30
7
13
2
11
4
EB
L 
(m
L)
 
96
2
45
0
30
0
50
0
35
0
87
5
37
0
45
5
20
0
52
0
31
9
54
8
20
9
62
1
Bl
oo
d 
tr
an
sf
us
io
n 
(%
)
N
S
N
S
7
8
16
46
N
S
N
S
0
17
11
15
0
36
H
os
pi
ta
l s
ta
y 
(d
)
8.
4
9.
8
1
5
5
8
13
.8
13
.7
3.
8
5.
6
2
5
2.
3
4.
0
Co
nv
er
si
on
 (%
)
0
0
12
.3
2.
2
0
5.
7
0
Co
m
pl
ic
at
io
n 
(%
)
4
9
13
4
8
6
44
17
6.
7
6.
7
2.
9
1.
9
23
.5
28
.6
Po
st
op
er
at
iv
e 
ad
ju
va
nt
 
30
33
22
21
14
4
20
11
.4
33
33
N
S
N
S
47
57
ch
em
or
ad
ia
tio
n 
(%
)
F/
U
 (m
on
)
24
17
21
52
49
26
20
41
7.
2
15
.2
31
46
Re
cu
rr
en
ce
 (%
)
3
0
5.
6
5.
6
4
4
13
.8
12
0
1
2.
9
3.
7
0
14
.3
Su
rv
iv
al
 (%
)
10
0
10
0
10
0
10
0
94
96
90
92
10
0
10
0
10
0
10
0
10
0
10
0
LS
=
la
pa
ro
sc
op
ic
; L
T
=
la
pa
ro
to
m
ic
; L
N
=
ly
m
ph
 n
od
e;
 E
BL
=
es
tim
at
ed
 b
lo
od
 lo
ss
.
Laparoscopic surgery in gynecological oncology
J Formos Med Assoc | 2010 • Vol 109 • No 8 561
be made during LS to minimize the risk of vagi-
nal recurrence, such as using a 1-0 Vicryl suture
to close the cervix as the first step during LS, and
avoiding manipulator use.29
Cervical Cancer
In recent years, vaginal radical surgery combined
with laparoscopic pelvic lymphadenectomy for
early-stage cervical cancer has gained recognition
in the field of oncology. Dargent30 was the first
to use the combined approach in 1987, and since
then, gynecological oncologists have used LS more
frequently in the management of cervical cancer,
and have concluded that it is feasible and effec-
tive.31–37 Patients with tumors less than 4 cm,
negative lymph nodes, and the absence of com-
bined angiovascular and lymphovascular space
involvement can be identified by LS, and are
ideal candidates for laparoscopic-assisted radical
hysterectomy.38 Studies that have compared LS
and laparotomy for radical hysterectomy of cervi-
cal cancer are listed in Table 2. This demonstrates
that early cervical cancer can be treated success-
fully with LS with similar efficacy and recurrence
rates to those of laparotomy. The major benefits
are less intraoperative blood loss and shorter
hospital stay.
In cervical cancer, one of the most important
prognostic factors is the status of the lymph
nodes. Approximately 7–15% of all patients with
early invasive cervical carcinoma are found to have
lymphatic spread, and removing pelvic and para-
aortic lymph nodes is an important part of the
staging procedure. LS has been used to perform
pelvic and para-aortic lymphadenectomy, along
with laparoscopic-assisted radical vaginal hys-
terectomy,39 total laparoscopic radical hysterec-
tomy,40,41 or laparoscopic-assisted radical vaginal
trachelectomy.42,43 Magrina et al44 compared three
groups: robotic-assisted laparoscopy, traditional
laparoscopy, and laparotomy, and concluded that
the robotic and laparoscopic groups were very
similar in their surgical outcomes, and that both
were preferable to laparotomy.
As a result of effective screening, an increasing
number of women are being diagnosed with cervi-
cal cancer at a younger age. Many of these women
are of childbearing age and wish to preserve their
fertility. Radical trachelectomy (RT) is a surgical
procedure that was developed by Daniel Dargent45
in the 1990s. This is the best fertility-sparing pro-
cedure for patients with early-stage cervical carci-
noma. It can be performed via laparotomy, but
most teams use a laparoscopic–vaginal approach—
lymphadenectomy is performed laparoscopically
and RT via a vaginal approach.42,43 Pregnancy
after RT is feasible and the majority (50–70%) of
patients who attempt to conceive succeed at least
once.46–48
Criteria for consideration for laparoscopic-
assisted radical vaginal trachelectomy42,43 include:
(1) childbearing age with the desire to preserve
fertility; (2) reasonable ability to conceive; (3)
FIGO stages IA2 to IB, with lesions less than 2 cm
in greatest dimension; (4) limited endocervical
involvement on colposcopy; (5) no positive lymph
nodes; (6) no lymphovascular space invasion; and
(7) adequate understanding and comprehension
of the procedure.49 It has been confirmed that
pregnancy is possible after RT but the premature
delivery rate is high.50 Prematurity is initiated by
premature rupture of the membranes because of
the absence of a cervical plug, which leads to as-
cending chorioamnionitis.50 Antibiotics should
be considered. The isthmic cerclage seems to be
efficient, but delivery by classical cesarean section
Table 3. Recurrences after laparoscopic or
laparotomic conservative surgery for
borderline ovarian tumors in the literatures
Maneo Romagnolo Fauvet 
et al [56] et al [59] et al [58]
LS LT LS LT LS LT
Number of cases 30 32 52 61 107 209
Rupture of the 53 22 34 7 34 12
cyst (%)
Cystectomy (%) 63 28 33 7 40 26
F/U (mon) 61 87 47 40 28 42
Recurrence (%) 37 22 13 10 12 9
Survival (%) 100 100 100 100 100 100
W.C. Chang, et al
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Figure 2. Operative procedures for laparoscopic pelvic lymphadenectomy. (A) Open the retroperitoneal space. Incision
of the lateral peritoneum is performed from the paracolic fossa to the round ligament of the uterus. The peritoneal inci-
sion is extended a few centimeters caudad towards the umbilical ligament (arrowhead). (B) Open the paravesical space.
The umbilical ligament is dissected, and then retracted medially with an atraumatic grasper. The paravesical space is
opened using simple diverging traction with the graspers. (C) Dissect the external iliac artery (EIA). The round ligament
is retracted laterally with a grasper to expose the EIA, which must be dissected along the adventitia of the vessel. The ex-
ternal nodal chain above the EIA is dissected using simple traction. This dissection is continued to the iliac junction. (D)
Dissect the external iliac vein (EIV). The surgeon then dissects the internal surface, followed by the superior surface of
the EIV. This makes it possible to obtain the nodes situated between the EIA and EIV. (E) Dissect the obturator nerve
(ON). The internal and inferior surfaces of the EIV are dissected. By dissecting free the lymph nodes, the surgeon can
identify the ON, which represents the deep limit of lymphadenectomy. Once identified, the nerve is dissected along the
portion that corresponds to lymphadenectomy. (F) The anatomical landmarks at the end of the procedure are: umbilical
ligament (arrowhead), EIA, EIV, ON, and ureter. EIA= external iliac artery; EIV= external iliac vein; ON= obturator nerve.
Laparoscopic surgery in gynecological oncology
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is necessary at the onset of labor or at 35–38 weeks’
gestation.51
Borderline Ovarian Tumors
Borderline ovarian tumors, also referred to as low-
malignant-potential tumors, represent 15% of ep-
ithelial ovarian tumors, and are characterized by
histological features of malignant tumors with-
out identifiable destructive stromal invasion.52
They occur predominantly among women of re-
productive age, with a recurrence rate of 10–20%
and have excellent prognosis. Therefore, fertility-
sparing is important and LS in borderline ovar-
ian tumors has become increasingly common.53,54
Fertility-sparing options can range from cystec-
tomy to adnexectomy, but patients who undergo
conservative ovarian cystectomy carry a substantial
risk of relapse, which can even develop after many
years.54–58 Therefore, when borderline ovarian
tumors are identified at surgery by intraoperative
histology, the recommended conservative treat-
ment is laparoscopic salpingo-oophorectomy.54
Table 3 shows the recurrence after LS or laparo-
tomy conservative surgery for borderline ovarian
tumors. Although the rate of intraoperative rup-
ture is higher for LS than laparotomy, it does not
affect the recurrence risk.56,58,59 Moreover, ovar-
ian cyst rupture is not related to the surgical route
but to the frequency of cystectomy.58 The rate of
recurrence after cystectomy is high, therefore, it is
suggested that laparoscopic cystectomy should
be considered only for women with one ovary or
with bilateral tumors who wish to preserve their
childbearing potential.54,57,58
Ovarian Cancer
Accurate surgical staging is pivotal for correct
management of all ovarian malignancies. Ac-
cording to the FIGO guidelines, complete surgical
staging should include total abdominal hysterec-
tomy, bilateral salpingo-oophorectomy, omentec-
tomy, pelvic lymph node dissection, and peritoneal
washings. Since the first report on the feasibility
of laparoscopic surgical staging for early-stage
ovarian cancer in 1994,60 gynecological oncolo-
gists have been using laparoscopic staging more
frequently in the management of ovarian can-
cer.1,61–65 Nezhat et al63 reported the longest mean
follow-up in a case series of 36 patients with in-
vasive ovarian carcinoma managed with LS, and
have concluded that LS is safe and efficacious in
staging early ovarian cancer. The mean duration
of follow-up was 55.9 months, and there was a
demonstrated 100% overall survival rate.63
Park1 compared the feasibility, accuracy, and
safety between LS and laparotomy staging of
early-stage ovarian cancer and found that they
show similar surgical staging adequacy and accu-
racy. Moreover, LS shows more favorable opera-
tive outcomes, such as shorter operating time,
lower transfusion requirement, faster return of
bowel movement, and shorter postoperative hos-
pital stay. In addition, LS has a shorter time inter-
val than laparotomy to adjuvant chemotherapy.
LS for staging early-stage ovarian cancer is also
thought to carry the risk of surgical tumor rup-
ture. However, it has been found that the inci-
dence of iatrogenic rupture of ovarian cancer was
similar in the LS and laparotomy groups (10.5%
vs.12.1%).1 After a median follow-up time of 17
months, there was no recurrence or death from
disease in either group.1 Therefore, LS can be an
alternative to LT for the treatment of early ovarian
cancer.
With regard to the possibility of fertility-sparing
surgery, some studies have demonstrated that well-
selected ovarian cancer patients, such as grade 1,
FIGO stage Ia, can safely benefit from conserva-
tive treatment as well.62,66,67 Moreover, if fertility-
sparing surgery is performed in clear-cell histotype,
grade 2–3, stage > Ia, platinum-based adjuvant
chemotherapy is indicated.62,66,67 However, longer
follow-up is needed to draw definitive conclusions
concerning survival data.
In conclusion, laparoscopy is selectively
adopted for the management of apparently early-
stage disease, defined as organ-confined cancer
with no evidence of gross metastatic disease, and
W.C. Chang, et al
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based upon preoperative imaging studies or 
laparoscopic inspection.
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